Balanced Optimism and Caution in Genpact's Strategic Shift: Hold Rating Amid Uncertain Long-term Impact
TD Cowen Maintains Genpact(G.US) With Hold Rating, Maintains Target Price $45
Mizuho Securities Maintains Genpact(G.US) With Hold Rating
Genpact: Balancing Growth Prospects With Challenges – Hold Rating Maintained
Deutsche Bank Adjusts Genpact Price Target to $48 From $37, Maintains Hold Rating
Genpact Is Maintained at Buy by Needham
A Quick Look at Today's Ratings for Genpact(G.US), With a Forecast Between $45 to $55
Genpact's Strong Q3 Performance and Strategic Growth Outlook Justify Buy Rating and Target Price Increase
A Quick Look at Today's Ratings for Genpact(G.US), With a Forecast Between $45 to $50
Genpact Is Maintained at Neutral by Baird
Genpact Analyst Ratings
Analysts Conflicted on These Technology Names: JFrog (FROG), Genpact (G) and Block (SQ)
Genpact's Strong Financial Performance and Strategic Positioning Lead to Buy Rating
Genpact's Promising Growth Trajectory Amidst Long-Term Uncertainty: Analyst Recommends Hold
Baird Maintains Genpact(G.US) With Hold Rating, Raises Target Price to $44
Baird Maintains Genpact(G.US) With Hold Rating, Raises Target Price to $44
Genpact Is Maintained at Neutral by Baird
Genpact Analyst Ratings
Jefferies Maintains Genpact(G.US) With Hold Rating, Raises Target Price to $40
Genpact Is Maintained at Neutral by JP Morgan